featured
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials
Diabetes Care 2024 Jun 01;47(6)1048-1055, LM Jacobsen, D Cuthbertson, BN Bundy, MA Atkinson, W Moore, MJ Haller, WE Russell, SE Gitelman, KC Herold, MJ Redondo, EK Sims, DK Wherrett, A Moran, A Pugliese, PA Gottlieb, JM Sosenko, HM IsmailFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.